PODD: Partnerships in Drug Delivery

October 7 - 8 Renaissance Boston Waterfront Hotel
image description
Sunrise is an Associate Sponsor and is delighted to be speaking.

Register Today!

Enter promo code SUNRISE25 to receive a 25% discount.

Visit us at: Booth #59

View Agenda

Don't miss Day Two: Oct 8
2:00 - 2:40 pm

Transforming the Injection Experience through a Patient-Centric Approach

In this session, panelists will address the following:
  • Industry Trends moving towards self-administration
  • Patient Perspective: Challenges with using complex drug delivery devices and training materials. 
  • Pharma Perspective: What can we as pharma companies do better with training materials? Performance & Usability Testing? Other blue sky ideas
  • Demo Units- how can they mimic the actual device in terms of use or performance
  • Training Videos & IFU- making it less cumbersome for our users.
 
Moderator: Panelists:          
Sudeshna Dutta Ray Natacha Montemuino Bryce Rutter Molly Story Alex Therrien Rémy Vomscheid
Sudeshna Dutta Ray
Amgen
Natacha Montemuino, MD
BD Medical
Bryce G Rutter PhD
Metaphase Design Group, Inc
Lilly Stairs
Savvy Cooperative
Molly Story, PhD
Sanofi
Alex Therrien
Sunrise Labs, Inc 
Rémy Vomscheid, PhD
Ipsen














The drug delivery industry is expected to experience robust growth over the next five to ten years, primarily due to the increasing prevalence of chronic conditions, increase in biologic drug approvals, and growing geriatric population. Often, the most complex part of developing a therapeutic is to design an appropriate delivery system for it. The use of drug delivery technologies will continue to rise, as the industry focuses on more cost-effective, targeted, and patient-centered therapies.

The 9th annual Partnership Opportunities in Drug Delivery (PODD) conference is a business development event covering the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships. The PODD event features a wide range of innovative drug delivery technologies that could potentially improve the delivery of various types of drugs, including proteins, peptides, oligonucleotides, biologics, and small molecules.